Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorSebri, Valeria
dc.contributor.authorMarzorati, Chiara
dc.contributor.authorDorangricchia , Patrizia
dc.contributor.authorMonzani, Dario
dc.contributor.authorGrasso, Roberto
dc.contributor.authorPRELAJ, ARSELA
dc.contributor.authorSoleda, Mireia
dc.contributor.authorArbusà Roca, Aina
dc.contributor.authorFELIP, ENRIQUETA
dc.date.accessioned2024-05-16T10:48:09Z
dc.date.available2024-05-16T10:48:09Z
dc.date.issued2024-05
dc.identifier.citationSebri V, Marzorati C, Dorangricchia P, Monzani D, Grasso R, Prelaj A, et al. The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project. Cancer Med. 2024 May;13(9):e7159.
dc.identifier.issn2045-7634
dc.identifier.urihttps://hdl.handle.net/11351/11466
dc.descriptionDecision‐making; Non‐small cell lung cancer; Patient knowledge
dc.description.abstractIntroduction To date, lung cancer is one of the most lethal diagnoses worldwide. A variety of lung cancer treatments and modalities are available, which are generally presented during the patient and doctor consultation. The implementation of decision tools to facilitate patient's decision-making and the management of their healthcare process during medical consultation is fundamental. Studies have demonstrated that decision tools are helpful to promote health management and decision-making of lung cancer patients during consultations. The main aim of the present work within the I3LUNG project is to systematically review the implementation of decision tools to facilitate medical consultation about oncological treatments for lung cancer patients. Methods In the present study, we conducted a systematic review following the PRISMA guidelines. We used an electronic computer-based search involving three databases, as follows: Embase, PubMed, and Scopus. 10 articles met the inclusion criteria and were included. They explicitly refer to decision tools in the oncological context, with lung cancer patients. Results The discussion highlights the most encouraging results about the positive role of decision aids during medical consultations about oncological treatments, especially regarding anxiety, decision-making, and patient knowledge. However, no one main decision aid tool emerged as essential. Opting for a more recent timeframe to select eligible articles might shed light on the current array of decision aid tools available. Conclusion Future review efforts could utilize alternative search strategies to explore other lung cancer-specific outcomes during medical consultations for treatment decisions and the implementation of decision aid tools. Engaging with experts in the fields of oncology, patient decision-making, or health communication could provide valuable insights and recommendations for relevant literature or research directions that may not be readily accessible through traditional search methods. The development of guidelines for future research were provided with the aim to promote decision aids focused on patients' needs.
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesCancer Medicine;13(9)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectPulmons - Càncer - Tractament
dc.subjectPacients - Participació
dc.subjectMedicina - Presa de decisions
dc.subject.meshLung Neoplasms
dc.subject.mesh/therapy
dc.subject.meshClinical Decision-Making
dc.subject.meshDecision Support Techniques
dc.titleThe impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/cam4.7159
dc.subject.decsneoplasias pulmonares
dc.subject.decs/terapia
dc.subject.decstoma de decisiones clínicas
dc.subject.decstécnicas de apoyo en la toma de decisiones
dc.relation.publishversionhttps://doi.org/10.1002/cam4.7159
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Sebri V, Marzorati C, Dorangricchia P] Applied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy. [Monzani D] Laboratory of Behavioral Observation and Research on Human Development, Department of Psychology, Educational Science and Human Movement, University of Palermo, Palermo, Italy. [Grasso R] Applied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. [Prelaj A] Thoracic Oncology Unit, Medical Oncology Department 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Department of Electronics, Information, and Bioengineering, Politecnico di Milano, Milan, Italy. [Felip E] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Soleda M, Arbusà Roca A] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid38741546
dc.relation.projectidinfo:eu-repo/grantAgreement/EC/H2020/101057695
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record